These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Regulation of prostate-specific antigen gene expression by an LH-RH analogue in human prostatic cells.
    Author: Sica G, Zelano G, Settesoldi D, Iacopino F.
    Journal: Anticancer Res; 2003; 23(2B):1283-7. PubMed ID: 12820384.
    Abstract:
    BACKGROUND: We investigated the regulation of prostate-specific antigen (PSA) gene expression in prostatic tumor cells by an LH-RH analogue, Leuprorelin acetate (LH-RHa), alone or combined with dihydrotestosterone (DHT). MATERIALS AND METHODS: PSA gene expression was evaluated by Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) in androgen-sensitive LNCaP and androgen-insensitive PC-3 cells. RESULTS: LH-RHa at both high and low concentrations induced a diminution in the levels of PSA gene expression which reached 70% in androgen-insensitive PC-3 cells. The analogue lowered the levels of expression obtained under DHT stimulation in LNCaP cells. These effects were visible from 6-24 hours of treatment and persisted until 120 hours. CONCLUSION: PSA gene expression is directly regulated by LH-RHa in both LNCaP and PC-3 cells. High concentrations of the analogue are particularly effective, but low doses of the drug have a similar behaviour. Interestingly, Leuprorelin acetate is able to counteract the androgen-induced gene expression. Our results suggest that, at least in androgen-sensitive cells, the analogue may regulate PSA gene expression also by interfering with the androgen receptor machinery.
    [Abstract] [Full Text] [Related] [New Search]